The Antiandrogen Bicalutamide Activates the Androgen Receptor (AR) With a Mutation in Codon 741 Through the Mitogen Activated Protein Kinase (MARK) Pathway in Human Prostate Cancer PC3 Cells
Oncology Reports - Greece
doi 10.3892/or_00000998
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2010
Authors
Unknown
Publisher
Spandidos Publications
